Our website uses cookies and similar technologies. By continuing to use our site, you are agreeing to our use of cookies and similar technologies. For more detail click here to read our Privacy Notice.

Trojan Global Equity Fund

The investment objective of the Fund is to seek to achieve capital growth over the long term (at least 5 years). The Fund must invest globally and at least 80% of its assets in equities and equity-related securities.

In addition to the O share class referred to on this page, I & S Classes are also available. Please contact us for more information.

'O' Share Class Price 22/09/2021
Accumulation Shares
Income Shares
422.93p
Fund Size
£449m (31/08/21)

Past performance is not a guide to future performance.

August 2021

Your Fund returned +3.5% during the month compared to +3.5% for the MSCI World Index NR (£).

The Fund’s collection of healthcare investments are an important and differentiated part of the portfolio. Six companies comprise ~22% of the portfolio’s total assets, and three of these – Agilent Technologies, Alcon and Medtronic – each reported encouraging financial results during August. News from Agilent and Alcon was especially well-received, and their share prices (in GBP) rose +16% and +14% respectively. This performance placed the holdings among the Fund’s top five contributors to returns in the month.

The Fund’s healthcare investments operate across disparate product categories. Agilent’s specialist equipment and consumables accurately measure the properties of substances used in scientific research and industrial applications.

Medtronic’s minimally invasive medical devices address cardio-vascular problems, general surgery, neuroscience and diabetes. Alcon leads in ophthalmic surgery, contact lenses and over-the-counter eye-care medicines.

Despite these differences, the companies share certain characteristics. All are recovering from the pandemic’s disruption in better shape. None have let the crisis go to waste. They continued to invest as sales declined and have each won additional market share with new products launched into areas where they already have commanding leadership positions. We remain optimistic about their improving trajectory because of rising commitments to R&D, which further fuels product innovation. Solving unmet medical needs allows these companies to capitalise on structurally growing demand for healthcare around the world.
.

Source: Lipper, Link Fund Solutions Limited

 

Total Return 06/03/2006
Since Launch
31/08/2011
10 Years
31/08/2016
5 Years
31/08/2018
3 Years
31/08/2020
1 Year
28/02/2021
6 Months
Trojan Global Equity O Acc +425.6% +272.2% +100.5% +57.2% +24.1% +22.3%
IA Global TR +263.5% +226.6% +85.2% +42.0% +26.5% +14.4%
MSCI World NR GBP +315.8% +272.1% +90.0% +43.5% +26.2% +18.0%
Discrete Calendar Annual Returns (%) 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Trojan Global Equity O Acc +20.2% -4.6% -11.3% +18.4% +14.9% +6.2% +3.7% +14.4% +15.0% +12.3% +19.2% +13.2% +1.1% +24.6% +13.5% +20.9%

Performance is calculated on a total return basis, net of fees, in sterling terms.

Source: Lipper, Link Fund Solutions Limited. Since Launch (06/03/2006) to 31 July 2021.

Source: Lipper, Link Fund Solutions Limited

 

Risk Analysis Since Launch (06/03/2006) Trojan Global Equity O Acc IA Global TR MSCI World NR GBP
Total Return +425.6% +263.5% +315.8%
Max Drawdown -33.3% -38.3% -38.3%
Best Month +9.4% +9.8% +10.1%
Worst Month -9.4% -12.9% -10.6%
Positive Months +62.7% +63.8% +63.8%
Annualised Volatility +11.6% +13.5% +13.4%

Performance is calculated on a total return basis, net of fees, in sterling terms.

Maximum Drawdown measures the worst investment period

Annualised Volatility is measured by the annualised standard deviation of the monthly returns 

Source: Lipper, Link Fund Solutions Limited.  

Top 10 holdings Fund %
Alphabet 8.8
Microsoft 8.2
Facebook 6.8
PayPal 6.7
Visa 5.2
Intuit 4.6
American Express 4.5
Roche Holding 4.3
Medtronic 4.3
Fiserv 3.7
Total Top 10 57.3
17 other holdings 42.1
Cash & Equivalent 0.6
Total 100.0

The Fund was originally launched as the Trojan Capital Fund, which focused on investing in UK equities with the flexibility to invest in overseas equities and other asset classes. The strategy was changed to a global equity strategy in December 2013. The Fund has been a constituent of the IA Global Sector since April 2012.  Prior to this, the Fund was in the IA Flexible Investment Sector. 

Past performance is not necessarily a guide to future performance. The value of a fund and any income from it may go down as well as up and investors may get back less than they invested. Changes in rates of exchange may cause the value of investments to go up or down. Returns may increase or decrease as a result of currency fluctuations​. This data is provided for information only and should not be reproduced, published or disseminated in any manner. Although Troy considers the data to be reliable, no warranty is given as to its accuracy or completeness. Any comparisons against indices are for illustrative purposes only.

How to Invest

You may invest directly, via a broker or adviser, or through a number of online fund platforms.

How to Invest

Troy Asset Management Limited ("Troy") is aware that fraudsters are using the trading name "Trojan Funds" in an attempt to defraud the public. The fraudulent URL (www.trojan-funds.com) is being used and emails are also being sent to members of the public in an attempt to commit investment fraud. We confirm that the trading name and email address which the fraudsters are using ([email protected]) are not linked with Troy or any funds managed by Troy, including Trojan Investment Funds and Trojan Funds (Ireland) plc.

Troy does not have any affiliation with "Trojan Funds" and has notified the relevant authorities of this scam. Troy will never contact members of the public to make any payments to us over the phone or via email in relation to making an investment. We urge you to stay alert to the dangers of investment fraud, even if documents or websites refer to genuine products and appear legitimate. Any potential investors should exercise extreme caution. Troy will take no responsibility for any potential losses you may incur.

If you believe you have received an email of this nature, or are in any doubt regarding the legitimacy of any communications purporting to be from Troy, please contact [email protected]. Further information on protecting yourself from scams can be found on the FCA website https://www.fca.org.uk/consumers/protect-yourself-scams. Alternatively you can report scams to the FCA at https://www.fca.org.uk/consumers/report-scam-us.
OK